Danaher Co. (NYSE:DHR) Shares Sold by Private Capital Advisors Inc.

Private Capital Advisors Inc. cut its holdings in shares of Danaher Co. (NYSE:DHR) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 58,024 shares of the conglomerate’s stock after selling 1,141 shares during the quarter. Danaher comprises approximately 1.6% of Private Capital Advisors Inc.’s investment portfolio, making the stock its 20th biggest position. Private Capital Advisors Inc.’s holdings in Danaher were worth $13,319,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. Hengehold Capital Management LLC lifted its holdings in shares of Danaher by 30.3% in the 4th quarter. Hengehold Capital Management LLC now owns 2,340 shares of the conglomerate’s stock worth $537,000 after acquiring an additional 544 shares during the last quarter. True North Advisors LLC lifted its stake in Danaher by 70.8% during the fourth quarter. True North Advisors LLC now owns 1,720 shares of the conglomerate’s stock worth $395,000 after purchasing an additional 713 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in shares of Danaher by 1.7% during the fourth quarter. Janney Montgomery Scott LLC now owns 184,484 shares of the conglomerate’s stock worth $42,349,000 after buying an additional 3,161 shares during the period. Daymark Wealth Partners LLC grew its stake in shares of Danaher by 0.9% in the fourth quarter. Daymark Wealth Partners LLC now owns 17,521 shares of the conglomerate’s stock valued at $4,022,000 after buying an additional 155 shares in the last quarter. Finally, Albion Financial Group UT raised its holdings in shares of Danaher by 360.7% in the 4th quarter. Albion Financial Group UT now owns 1,290 shares of the conglomerate’s stock valued at $296,000 after buying an additional 1,010 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have weighed in on DHR. Raymond James cut their price target on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research note on Tuesday. UBS Group reduced their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Evercore ISI upped their price objective on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. TD Cowen lifted their target price on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $285.55.

Danaher Price Performance

Shares of NYSE DHR opened at $245.73 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a market cap of $177.49 billion, a P/E ratio of 46.90, a P/E/G ratio of 4.43 and a beta of 0.83. The stock has a 50 day moving average of $234.90 and a two-hundred day moving average of $253.47. Danaher Co. has a twelve month low of $225.42 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the firm posted $2.02 EPS. Danaher’s revenue for the quarter was up 3.1% on a year-over-year basis. On average, research analysts forecast that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.